Antidote Therapeutics

Developing nicotine-blockers to treat diseases caused by nicotine and addiction

placeGaithersburg, Maryland, United States calendar_todayFounded 2017 groups3 employees language antidotetx.com

Innovation

5 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 209 times.

YearFilings
20182
20194
20203
20212
20223
20232
20252

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon